These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 9586154

  • 1. [Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results in 66 patients with reference to myocardial contrast echocardiography].
    Faber L, Seggewiss H, Fassbender D, Bogunovic N, Strick S, Schmidt HK, Gleichmann U.
    Z Kardiol; 1998 Mar; 87(3):191-201. PubMed ID: 9586154
    [Abstract] [Full Text] [Related]

  • 2. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients.
    Seggewiss H, Gleichmann U, Faber L, Fassbender D, Schmidt HK, Strick S.
    J Am Coll Cardiol; 1998 Feb; 31(2):252-8. PubMed ID: 9462563
    [Abstract] [Full Text] [Related]

  • 3. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography.
    Faber L, Seggewiss H, Gleichmann U.
    Circulation; 1998 Dec 01; 98(22):2415-21. PubMed ID: 9832486
    [Abstract] [Full Text] [Related]

  • 4. Percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy.
    Seggewiss H, Faber L, Gleichmann U.
    Thorac Cardiovasc Surg; 1999 Apr 01; 47(2):94-100. PubMed ID: 10363608
    [Abstract] [Full Text] [Related]

  • 5. [Percutaneous transluminal septal myocardial ablation: early results and long-term follow-up].
    Tekieli Ł, Pieniazek P, Podolec P, Tomkiewicz-Pajak L, Płazak W, Musiałek P, Leśniak-Sobelga A, Przewłocki T, Biernacka B, Zmudka K, Tracz W.
    Przegl Lek; 2006 Apr 01; 63(8):628-32. PubMed ID: 17441371
    [Abstract] [Full Text] [Related]

  • 6. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute results and three-year noninvasive follow-up in 18 patients.
    Guo H, Wang J, Chen J, Shan J, Lee JD, Ueda T.
    Can J Cardiol; 2004 Jun 01; 20(8):779-82. PubMed ID: 15229758
    [Abstract] [Full Text] [Related]

  • 7. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: long term follow up of the first series of 25 patients.
    Faber L, Meissner A, Ziemssen P, Seggewiss H.
    Heart; 2000 Mar 01; 83(3):326-31. PubMed ID: 10677415
    [Abstract] [Full Text] [Related]

  • 8. Echo-guided percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: 7 years of experience.
    Faber L, Seggewiss H, Welge D, Fassbender D, Schmidt HK, Gleichmann U, Horstkotte D.
    Eur J Echocardiogr; 2004 Oct 01; 5(5):347-55. PubMed ID: 15341870
    [Abstract] [Full Text] [Related]

  • 9. Simultaneous percutaneous treatment in hypertrophic obstructive cardiomyopathy and coronary artery disease: a case report.
    Seggewiss H, Faber L, Meyners W, Bogunovic N, Odenthal HJ, Gleichmann U.
    Cathet Cardiovasc Diagn; 1998 May 01; 44(1):65-9. PubMed ID: 9600527
    [Abstract] [Full Text] [Related]

  • 10. Early remodelling of left ventricle and improvement of myocardial performance in patients after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.
    Veselka J, Honek T.
    Int J Cardiol; 2003 Mar 01; 88(1):27-32. PubMed ID: 12659981
    [Abstract] [Full Text] [Related]

  • 11. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.
    Tsuchikane E, Takeda Y, Kobayashi T, Yachiku K, Nasu K, Kobayashi Y, Matsumoto H, Awata N.
    Circ J; 2003 Sep 01; 67(9):763-7. PubMed ID: 12939552
    [Abstract] [Full Text] [Related]

  • 12. Long-term follow-up after percutaneous septal ablation in hypertrophic obstructive cardiomyopathy.
    Seggewiss H, Rigopoulos A, Welge D, Ziemssen P, Faber L.
    Clin Res Cardiol; 2007 Dec 01; 96(12):856-63. PubMed ID: 17891517
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Percutaneous transluminal septal myocardial ablation in drug-resistant hypertrophic obstructive cardiomyopathy: 18-month follow-up results.
    Oomman A, Ramachandran P, Subramanyan K, Kalarickal MS, Osman MN.
    J Invasive Cardiol; 2001 Jul 01; 13(7):526-30. PubMed ID: 11435640
    [Abstract] [Full Text] [Related]

  • 17. Catheter-based septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: follow-up results of the TASH-registry of the German Cardiac Society.
    Faber L, Seggewiss H, Gietzen FH, Kuhn H, Boekstegers P, Neuhaus L, Seipel L, Horstkotte D.
    Z Kardiol; 2005 Aug 01; 94(8):516-23. PubMed ID: 16049653
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: managing the risk of procedure-related AV conduction disturbances.
    Faber L, Welge D, Fassbender D, Schmidt HK, Horstkotte D, Seggewiss H.
    Int J Cardiol; 2007 Jul 10; 119(2):163-7. PubMed ID: 17067708
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.